INDIANA – Public health data indicates that a late-summer COVID-19 surge has arrived across the United States, likely driven by seasonal exposure patterns, time spent in air-conditioned indoor environments, and waning population immunity.
While overall case counts remain relatively low compared to past peaks, estimates from the Centers for Disease Control and Prevention (CDC) show that infections are growing or likely growing in all 50 states. Surveillance data from WastewaterSCAN also reveals that viral concentrations in wastewater nationwide have reached high levels following a three-week upward trend. Emergency room visits and hospitalizations have experienced slight increases, though experts note that the overall risk for severe illness, hospitalization, and death remains extremely low for the general public.
Overlapping Symptoms Make Diagnosis Challenging
Distinguishing between COVID-19 and a standard summer cold is difficult without formal testing due to substantial symptom overlap. Common symptoms shared across both infections include:
- Runny nose and congestion
- Sore throat
- Cough
- Fatigue
- Fever
Specific circulating variants may present unique characteristics. While the XFG strain is currently the predominant variant in the U.S., the NB.1.8.1 strain remains in circulation and has been associated with severe throat soreness. Older signature symptoms, such as the loss of taste or smell, are observed less frequently with current strains.
Testing and Antiviral Treatments
Health experts emphasize that at-home or laboratory testing is the only definitive way to confirm a COVID-19 infection. Testing is particularly critical for high-risk individuals—including adults aged 65 and older and those with underlying health conditions or weakened immune systems—as well as those who interact with vulnerable populations.
For high-risk individuals, early diagnosis allows access to prescription antiviral treatments such as Paxlovid, Veklury, or Lageviro. These medications must be initiated within five to seven days of initial symptom onset to reduce the likelihood of severe disease or long-term complications.
Vaccination Guidance
Updated COVID-19 vaccines targeting the XFG strain are anticipated to be available in the fall. Public health officials offer the following guidance regarding current timing:
- General Public: Healthy individuals are generally advised to wait for the updated fall vaccine formula.
- High-Risk Groups: Seniors and immunocompromised individuals who have not received a recent dose may benefit from consulting a healthcare provider about receiving a vaccine immediately to boost waning immunity.
Basic preventive measures—such as maintaining good hand hygiene, staying home when ill, avoiding crowded indoor spaces, and wearing masks in high-risk environments—remain recommended to reduce transmission.
